nodes	percent_of_prediction	percent_of_DWPC	metapath
Amitriptyline—HTR7—Parkinson's disease	0.132	0.19	CbGaD
Amitriptyline—DRD3—Parkinson's disease	0.124	0.178	CbGaD
Amitriptyline—HTR1A—Parkinson's disease	0.101	0.145	CbGaD
Amitriptyline—DRD2—Parkinson's disease	0.0859	0.123	CbGaD
Amitriptyline—CYP2E1—Parkinson's disease	0.0827	0.119	CbGaD
Amitriptyline—HTR2A—Parkinson's disease	0.0664	0.0953	CbGaD
Amitriptyline—CYP2D6—Parkinson's disease	0.0607	0.0872	CbGaD
Amitriptyline—ABCB1—Parkinson's disease	0.0434	0.0623	CbGaD
Amitriptyline—KCND2—midbrain—Parkinson's disease	0.000437	0.0036	CbGeAlD
Amitriptyline—KCNQ3—head—Parkinson's disease	0.000435	0.00358	CbGeAlD
Amitriptyline—HTR1A—hindbrain—Parkinson's disease	0.000433	0.00357	CbGeAlD
Amitriptyline—KCND2—spinal cord—Parkinson's disease	0.000427	0.00351	CbGeAlD
Amitriptyline—NTRK2—brain—Parkinson's disease	0.000416	0.00343	CbGeAlD
Amitriptyline—HTR7—hindbrain—Parkinson's disease	0.000414	0.00341	CbGeAlD
Amitriptyline—KCNQ3—nervous system—Parkinson's disease	0.000412	0.0034	CbGeAlD
Amitriptyline—KCNQ2—head—Parkinson's disease	0.0004	0.0033	CbGeAlD
Amitriptyline—ADRA1A—hindbrain—Parkinson's disease	0.000399	0.00329	CbGeAlD
Amitriptyline—KCNQ3—central nervous system—Parkinson's disease	0.000397	0.00327	CbGeAlD
Amitriptyline—DRD2—hindbrain—Parkinson's disease	0.000391	0.00322	CbGeAlD
Amitriptyline—KCNQ3—cerebellum—Parkinson's disease	0.000388	0.0032	CbGeAlD
Amitriptyline—ADRA1D—forebrain—Parkinson's disease	0.000384	0.00317	CbGeAlD
Amitriptyline—KCNA1—midbrain—Parkinson's disease	0.000383	0.00316	CbGeAlD
Amitriptyline—KCND3—midbrain—Parkinson's disease	0.000381	0.00314	CbGeAlD
Amitriptyline—HRH2—cardiovascular system—Parkinson's disease	0.00038	0.00313	CbGeAlD
Amitriptyline—KCNQ2—nervous system—Parkinson's disease	0.00038	0.00313	CbGeAlD
Amitriptyline—KCND2—head—Parkinson's disease	0.000379	0.00312	CbGeAlD
Amitriptyline—KCNA1—spinal cord—Parkinson's disease	0.000374	0.00308	CbGeAlD
Amitriptyline—KCNQ2—central nervous system—Parkinson's disease	0.000365	0.00301	CbGeAlD
Amitriptyline—KCND2—nervous system—Parkinson's disease	0.000359	0.00296	CbGeAlD
Amitriptyline—KCNQ2—cerebellum—Parkinson's disease	0.000357	0.00294	CbGeAlD
Amitriptyline—KCND2—central nervous system—Parkinson's disease	0.000346	0.00285	CbGeAlD
Amitriptyline—HTR2A—nerve—Parkinson's disease	0.000344	0.00284	CbGeAlD
Amitriptyline—KCND2—cerebellum—Parkinson's disease	0.000338	0.00279	CbGeAlD
Amitriptyline—OPRM1—brainstem—Parkinson's disease	0.000336	0.00277	CbGeAlD
Amitriptyline—KCNA1—head—Parkinson's disease	0.000332	0.00274	CbGeAlD
Amitriptyline—KCND3—head—Parkinson's disease	0.000331	0.00272	CbGeAlD
Amitriptyline—OPRM1—forebrain—Parkinson's disease	0.000324	0.00267	CbGeAlD
Amitriptyline—KCNQ3—brain—Parkinson's disease	0.000315	0.0026	CbGeAlD
Amitriptyline—KCNA1—nervous system—Parkinson's disease	0.000315	0.0026	CbGeAlD
Amitriptyline—CHRM4—head—Parkinson's disease	0.000315	0.00259	CbGeAlD
Amitriptyline—KCND3—nervous system—Parkinson's disease	0.000313	0.00258	CbGeAlD
Amitriptyline—HTR1B—brainstem—Parkinson's disease	0.000307	0.00253	CbGeAlD
Amitriptyline—KCNA1—central nervous system—Parkinson's disease	0.000303	0.0025	CbGeAlD
Amitriptyline—KCND3—central nervous system—Parkinson's disease	0.000302	0.00249	CbGeAlD
Amitriptyline—CHRM4—nervous system—Parkinson's disease	0.000299	0.00246	CbGeAlD
Amitriptyline—HTR1D—brainstem—Parkinson's disease	0.000298	0.00245	CbGeAlD
Amitriptyline—HTR1B—forebrain—Parkinson's disease	0.000297	0.00244	CbGeAlD
Amitriptyline—KCNA1—cerebellum—Parkinson's disease	0.000296	0.00244	CbGeAlD
Amitriptyline—CHRM2—forebrain—Parkinson's disease	0.000295	0.00243	CbGeAlD
Amitriptyline—KCND3—cerebellum—Parkinson's disease	0.000295	0.00243	CbGeAlD
Amitriptyline—HTR2C—brainstem—Parkinson's disease	0.000295	0.00243	CbGeAlD
Amitriptyline—DRD3—head—Parkinson's disease	0.000293	0.00241	CbGeAlD
Amitriptyline—KCNQ2—brain—Parkinson's disease	0.00029	0.00239	CbGeAlD
Amitriptyline—CHRM4—central nervous system—Parkinson's disease	0.000287	0.00237	CbGeAlD
Amitriptyline—HTR1D—forebrain—Parkinson's disease	0.000287	0.00237	CbGeAlD
Amitriptyline—HTR2C—forebrain—Parkinson's disease	0.000284	0.00234	CbGeAlD
Amitriptyline—HTR6—head—Parkinson's disease	0.000282	0.00232	CbGeAlD
Amitriptyline—SLC6A4—brainstem—Parkinson's disease	0.000279	0.0023	CbGeAlD
Amitriptyline—DRD3—nervous system—Parkinson's disease	0.000278	0.00229	CbGeAlD
Amitriptyline—KCND2—brain—Parkinson's disease	0.000275	0.00226	CbGeAlD
Amitriptyline—OPRD1—head—Parkinson's disease	0.000272	0.00224	CbGeAlD
Amitriptyline—SLC6A4—forebrain—Parkinson's disease	0.00027	0.00222	CbGeAlD
Amitriptyline—CHRM1—forebrain—Parkinson's disease	0.000269	0.00221	CbGeAlD
Amitriptyline—DRD3—central nervous system—Parkinson's disease	0.000267	0.0022	CbGeAlD
Amitriptyline—HTR6—nervous system—Parkinson's disease	0.000267	0.0022	CbGeAlD
Amitriptyline—OPRK1—head—Parkinson's disease	0.000261	0.00215	CbGeAlD
Amitriptyline—OPRD1—nervous system—Parkinson's disease	0.000258	0.00213	CbGeAlD
Amitriptyline—HTR2A—hindbrain—Parkinson's disease	0.000258	0.00212	CbGeAlD
Amitriptyline—HRH2—head—Parkinson's disease	0.000258	0.00212	CbGeAlD
Amitriptyline—HTR6—central nervous system—Parkinson's disease	0.000257	0.00212	CbGeAlD
Amitriptyline—HTR1B—cardiovascular system—Parkinson's disease	0.000251	0.00207	CbGeAlD
Amitriptyline—CHRM2—cardiovascular system—Parkinson's disease	0.000249	0.00206	CbGeAlD
Amitriptyline—OPRD1—central nervous system—Parkinson's disease	0.000248	0.00205	CbGeAlD
Amitriptyline—HTR1A—brainstem—Parkinson's disease	0.000248	0.00204	CbGeAlD
Amitriptyline—OPRK1—nervous system—Parkinson's disease	0.000247	0.00204	CbGeAlD
Amitriptyline—CHRM5—head—Parkinson's disease	0.000246	0.00203	CbGeAlD
Amitriptyline—SLC6A2—brainstem—Parkinson's disease	0.000246	0.00203	CbGeAlD
Amitriptyline—HRH2—nervous system—Parkinson's disease	0.000244	0.00201	CbGeAlD
Amitriptyline—HTR1D—cardiovascular system—Parkinson's disease	0.000243	0.002	CbGeAlD
Amitriptyline—Epinastine—HTR7—Parkinson's disease	0.000241	0.0406	CrCbGaD
Amitriptyline—KCNA1—brain—Parkinson's disease	0.000241	0.00198	CbGeAlD
Amitriptyline—CHRM3—forebrain—Parkinson's disease	0.00024	0.00198	CbGeAlD
Amitriptyline—KCND3—brain—Parkinson's disease	0.00024	0.00197	CbGeAlD
Amitriptyline—HTR1A—forebrain—Parkinson's disease	0.000239	0.00197	CbGeAlD
Amitriptyline—OPRK1—central nervous system—Parkinson's disease	0.000238	0.00196	CbGeAlD
Amitriptyline—SLC6A2—forebrain—Parkinson's disease	0.000237	0.00196	CbGeAlD
Amitriptyline—HTR7—brainstem—Parkinson's disease	0.000237	0.00195	CbGeAlD
Amitriptyline—HRH2—central nervous system—Parkinson's disease	0.000235	0.00194	CbGeAlD
Amitriptyline—CYP2D6—hindbrain—Parkinson's disease	0.000235	0.00194	CbGeAlD
Amitriptyline—CHRM5—nervous system—Parkinson's disease	0.000233	0.00192	CbGeAlD
Amitriptyline—OPRK1—cerebellum—Parkinson's disease	0.000233	0.00192	CbGeAlD
Amitriptyline—HTR7—forebrain—Parkinson's disease	0.000229	0.00188	CbGeAlD
Amitriptyline—ADRA1A—brainstem—Parkinson's disease	0.000229	0.00188	CbGeAlD
Amitriptyline—CHRM4—brain—Parkinson's disease	0.000228	0.00188	CbGeAlD
Amitriptyline—CHRM1—cardiovascular system—Parkinson's disease	0.000227	0.00187	CbGeAlD
Amitriptyline—ADRA1B—head—Parkinson's disease	0.000225	0.00185	CbGeAlD
Amitriptyline—CHRM5—central nervous system—Parkinson's disease	0.000225	0.00185	CbGeAlD
Amitriptyline—DRD2—brainstem—Parkinson's disease	0.000224	0.00185	CbGeAlD
Amitriptyline—ADRA1A—forebrain—Parkinson's disease	0.000221	0.00182	CbGeAlD
Amitriptyline—ADRA1D—head—Parkinson's disease	0.00022	0.00181	CbGeAlD
Amitriptyline—DRD2—forebrain—Parkinson's disease	0.000216	0.00178	CbGeAlD
Amitriptyline—OPRM1—midbrain—Parkinson's disease	0.000214	0.00176	CbGeAlD
Amitriptyline—ADRA1B—nervous system—Parkinson's disease	0.000213	0.00176	CbGeAlD
Amitriptyline—DRD3—brain—Parkinson's disease	0.000212	0.00175	CbGeAlD
Amitriptyline—OPRM1—spinal cord—Parkinson's disease	0.000209	0.00172	CbGeAlD
Amitriptyline—ADRA1D—nervous system—Parkinson's disease	0.000209	0.00172	CbGeAlD
Amitriptyline—HTR2C—medulla oblongata—Parkinson's disease	0.000205	0.00169	CbGeAlD
Amitriptyline—ADRA1B—central nervous system—Parkinson's disease	0.000205	0.00169	CbGeAlD
Amitriptyline—HTR6—brain—Parkinson's disease	0.000204	0.00168	CbGeAlD
Amitriptyline—ORM1—spinal cord—Parkinson's disease	0.000204	0.00168	CbGeAlD
Amitriptyline—HTR1A—cardiovascular system—Parkinson's disease	0.000202	0.00167	CbGeAlD
Amitriptyline—ADRA1D—central nervous system—Parkinson's disease	0.000201	0.00165	CbGeAlD
Amitriptyline—OPRD1—brain—Parkinson's disease	0.000197	0.00162	CbGeAlD
Amitriptyline—HTR1B—midbrain—Parkinson's disease	0.000196	0.00161	CbGeAlD
Amitriptyline—SIGMAR1—medulla oblongata—Parkinson's disease	0.000193	0.00159	CbGeAlD
Amitriptyline—HTR7—cardiovascular system—Parkinson's disease	0.000193	0.00159	CbGeAlD
Amitriptyline—HTR1B—spinal cord—Parkinson's disease	0.000191	0.00157	CbGeAlD
Amitriptyline—HTR1D—midbrain—Parkinson's disease	0.00019	0.00156	CbGeAlD
Amitriptyline—OPRK1—brain—Parkinson's disease	0.000189	0.00156	CbGeAlD
Amitriptyline—HTR2C—midbrain—Parkinson's disease	0.000188	0.00155	CbGeAlD
Amitriptyline—HRH2—brain—Parkinson's disease	0.000187	0.00154	CbGeAlD
Amitriptyline—ADRA1A—cardiovascular system—Parkinson's disease	0.000187	0.00154	CbGeAlD
Amitriptyline—OPRM1—head—Parkinson's disease	0.000186	0.00153	CbGeAlD
Amitriptyline—HTR2C—spinal cord—Parkinson's disease	0.000183	0.00151	CbGeAlD
Amitriptyline—CHRM5—brain—Parkinson's disease	0.000178	0.00147	CbGeAlD
Amitriptyline—SLC6A4—midbrain—Parkinson's disease	0.000178	0.00147	CbGeAlD
Amitriptyline—SIGMAR1—midbrain—Parkinson's disease	0.000177	0.00146	CbGeAlD
Amitriptyline—OPRM1—nervous system—Parkinson's disease	0.000176	0.00145	CbGeAlD
Amitriptyline—SLC6A4—spinal cord—Parkinson's disease	0.000174	0.00143	CbGeAlD
Amitriptyline—SIGMAR1—spinal cord—Parkinson's disease	0.000172	0.00142	CbGeAlD
Amitriptyline—ORM1—nervous system—Parkinson's disease	0.000172	0.00142	CbGeAlD
Amitriptyline—SLC6A2—medulla oblongata—Parkinson's disease	0.000171	0.00141	CbGeAlD
Amitriptyline—HRH1—forebrain—Parkinson's disease	0.000171	0.00141	CbGeAlD
Amitriptyline—HTR1B—head—Parkinson's disease	0.00017	0.0014	CbGeAlD
Amitriptyline—OPRM1—central nervous system—Parkinson's disease	0.000169	0.0014	CbGeAlD
Amitriptyline—CHRM2—head—Parkinson's disease	0.000169	0.00139	CbGeAlD
Amitriptyline—ADRA2A—forebrain—Parkinson's disease	0.000168	0.00138	CbGeAlD
Amitriptyline—ORM1—central nervous system—Parkinson's disease	0.000165	0.00136	CbGeAlD
Amitriptyline—HTR7—medulla oblongata—Parkinson's disease	0.000165	0.00136	CbGeAlD
Amitriptyline—HTR1D—head—Parkinson's disease	0.000164	0.00135	CbGeAlD
Amitriptyline—ADRA1B—brain—Parkinson's disease	0.000163	0.00134	CbGeAlD
Amitriptyline—HTR2C—head—Parkinson's disease	0.000163	0.00134	CbGeAlD
Amitriptyline—HTR2A—embryo—Parkinson's disease	0.000161	0.00133	CbGeAlD
Amitriptyline—HTR1B—nervous system—Parkinson's disease	0.000161	0.00133	CbGeAlD
Amitriptyline—CHRM2—nervous system—Parkinson's disease	0.00016	0.00132	CbGeAlD
Amitriptyline—ADRA1D—brain—Parkinson's disease	0.000159	0.00131	CbGeAlD
Amitriptyline—HTR1A—midbrain—Parkinson's disease	0.000158	0.0013	CbGeAlD
Amitriptyline—HTR1D—nervous system—Parkinson's disease	0.000156	0.00128	CbGeAlD
Amitriptyline—Clomipramine—GSTP1—Parkinson's disease	0.000156	0.0262	CrCbGaD
Amitriptyline—HTR1B—central nervous system—Parkinson's disease	0.000155	0.00128	CbGeAlD
Amitriptyline—HTR2C—nervous system—Parkinson's disease	0.000154	0.00127	CbGeAlD
Amitriptyline—SLC6A4—head—Parkinson's disease	0.000154	0.00127	CbGeAlD
Amitriptyline—HTR1A—spinal cord—Parkinson's disease	0.000154	0.00127	CbGeAlD
Amitriptyline—CHRM2—central nervous system—Parkinson's disease	0.000154	0.00127	CbGeAlD
Amitriptyline—CHRM1—head—Parkinson's disease	0.000154	0.00127	CbGeAlD
Amitriptyline—HTR7—midbrain—Parkinson's disease	0.000151	0.00124	CbGeAlD
Amitriptyline—HTR1D—central nervous system—Parkinson's disease	0.00015	0.00124	CbGeAlD
Amitriptyline—Thiothixene—DRD1—Parkinson's disease	0.000149	0.0251	CrCbGaD
Amitriptyline—HTR2C—central nervous system—Parkinson's disease	0.000149	0.00122	CbGeAlD
Amitriptyline—CYP2B6—cardiovascular system—Parkinson's disease	0.000148	0.00122	CbGeAlD
Amitriptyline—HTR2A—brainstem—Parkinson's disease	0.000148	0.00122	CbGeAlD
Amitriptyline—HTR7—spinal cord—Parkinson's disease	0.000147	0.00121	CbGeAlD
Amitriptyline—CYP2C9—cardiovascular system—Parkinson's disease	0.000146	0.00121	CbGeAlD
Amitriptyline—SLC6A4—nervous system—Parkinson's disease	0.000146	0.00121	CbGeAlD
Amitriptyline—CHRM1—nervous system—Parkinson's disease	0.000146	0.0012	CbGeAlD
Amitriptyline—DRD2—midbrain—Parkinson's disease	0.000143	0.00118	CbGeAlD
Amitriptyline—HTR2A—forebrain—Parkinson's disease	0.000143	0.00118	CbGeAlD
Amitriptyline—Cyproheptadine—HTR1A—Parkinson's disease	0.000141	0.0238	CrCbGaD
Amitriptyline—SLC6A4—central nervous system—Parkinson's disease	0.000141	0.00116	CbGeAlD
Amitriptyline—CHRM1—central nervous system—Parkinson's disease	0.00014	0.00116	CbGeAlD
Amitriptyline—Mianserin—HTR7—Parkinson's disease	0.000139	0.0235	CrCbGaD
Amitriptyline—CYP2E1—cardiovascular system—Parkinson's disease	0.000139	0.00114	CbGeAlD
Amitriptyline—CHRM3—head—Parkinson's disease	0.000138	0.00113	CbGeAlD
Amitriptyline—HTR1A—head—Parkinson's disease	0.000137	0.00113	CbGeAlD
Amitriptyline—SIGMAR1—cerebellum—Parkinson's disease	0.000137	0.00113	CbGeAlD
Amitriptyline—SLC6A2—head—Parkinson's disease	0.000136	0.00112	CbGeAlD
Amitriptyline—CYP2D6—brainstem—Parkinson's disease	0.000135	0.00111	CbGeAlD
Amitriptyline—OPRM1—brain—Parkinson's disease	0.000134	0.00111	CbGeAlD
Amitriptyline—Tripelennamine—CYP2D6—Parkinson's disease	0.000134	0.0226	CrCbGaD
Amitriptyline—Aprindine—CYP2D6—Parkinson's disease	0.000131	0.0221	CrCbGaD
Amitriptyline—Mianserin—DRD3—Parkinson's disease	0.000131	0.0221	CrCbGaD
Amitriptyline—HTR7—head—Parkinson's disease	0.000131	0.00108	CbGeAlD
Amitriptyline—CHRM3—nervous system—Parkinson's disease	0.00013	0.00107	CbGeAlD
Amitriptyline—CYP2D6—forebrain—Parkinson's disease	0.00013	0.00107	CbGeAlD
Amitriptyline—HTR1A—nervous system—Parkinson's disease	0.00013	0.00107	CbGeAlD
Amitriptyline—SLC6A2—nervous system—Parkinson's disease	0.000129	0.00106	CbGeAlD
Amitriptyline—ADRA1A—head—Parkinson's disease	0.000126	0.00104	CbGeAlD
Amitriptyline—CHRM3—central nervous system—Parkinson's disease	0.000126	0.00103	CbGeAlD
Amitriptyline—HTR1A—central nervous system—Parkinson's disease	0.000125	0.00103	CbGeAlD
Amitriptyline—HTR7—nervous system—Parkinson's disease	0.000124	0.00102	CbGeAlD
Amitriptyline—SLC6A2—central nervous system—Parkinson's disease	0.000124	0.00102	CbGeAlD
Amitriptyline—DRD2—head—Parkinson's disease	0.000124	0.00102	CbGeAlD
Amitriptyline—Thiothixene—HTR1A—Parkinson's disease	0.000124	0.0208	CrCbGaD
Amitriptyline—HTR1B—brain—Parkinson's disease	0.000123	0.00101	CbGeAlD
Amitriptyline—CHRM2—brain—Parkinson's disease	0.000122	0.00101	CbGeAlD
Amitriptyline—HTR1A—cerebellum—Parkinson's disease	0.000122	0.00101	CbGeAlD
Amitriptyline—Cyclobenzaprine—HTR2A—Parkinson's disease	0.000122	0.0206	CrCbGaD
Amitriptyline—Mianserin—SLC6A3—Parkinson's disease	0.000122	0.0206	CrCbGaD
Amitriptyline—ADRA2A—medulla oblongata—Parkinson's disease	0.000121	0.000999	CbGeAlD
Amitriptyline—Epinastine—HTR2A—Parkinson's disease	0.000121	0.0204	CrCbGaD
Amitriptyline—HTR2A—cardiovascular system—Parkinson's disease	0.000121	0.000994	CbGeAlD
Amitriptyline—ADRA1A—nervous system—Parkinson's disease	0.00012	0.000987	CbGeAlD
Amitriptyline—Cyproheptadine—DRD2—Parkinson's disease	0.00012	0.0202	CrCbGaD
Amitriptyline—HTR7—central nervous system—Parkinson's disease	0.00012	0.000985	CbGeAlD
Amitriptyline—Chlorprothixene—DRD3—Parkinson's disease	0.000119	0.0201	CrCbGaD
Amitriptyline—HTR1D—brain—Parkinson's disease	0.000119	0.000982	CbGeAlD
Amitriptyline—CYP2E1—medulla oblongata—Parkinson's disease	0.000119	0.000977	CbGeAlD
Amitriptyline—HTR2C—brain—Parkinson's disease	0.000118	0.000972	CbGeAlD
Amitriptyline—DRD2—nervous system—Parkinson's disease	0.000117	0.000967	CbGeAlD
Amitriptyline—Chlorprothixene—DRD1—Parkinson's disease	0.000117	0.0197	CrCbGaD
Amitriptyline—HTR7—cerebellum—Parkinson's disease	0.000117	0.000963	CbGeAlD
Amitriptyline—ADRA1A—central nervous system—Parkinson's disease	0.000115	0.00095	CbGeAlD
Amitriptyline—ALB—brain—Parkinson's disease	0.000115	0.000949	CbGeAlD
Amitriptyline—DRD2—central nervous system—Parkinson's disease	0.000113	0.000931	CbGeAlD
Amitriptyline—ADRA1A—cerebellum—Parkinson's disease	0.000113	0.000929	CbGeAlD
Amitriptyline—SLC6A4—brain—Parkinson's disease	0.000112	0.000922	CbGeAlD
Amitriptyline—Cyclobenzaprine—CYP2D6—Parkinson's disease	0.000112	0.0188	CrCbGaD
Amitriptyline—CHRM1—brain—Parkinson's disease	0.000111	0.000918	CbGeAlD
Amitriptyline—SIGMAR1—brain—Parkinson's disease	0.000111	0.000915	CbGeAlD
Amitriptyline—ADRA2A—midbrain—Parkinson's disease	0.000111	0.000913	CbGeAlD
Amitriptyline—Epinastine—CYP2D6—Parkinson's disease	0.000111	0.0187	CrCbGaD
Amitriptyline—DRD2—cerebellum—Parkinson's disease	0.00011	0.00091	CbGeAlD
Amitriptyline—ADRA2A—spinal cord—Parkinson's disease	0.000108	0.000891	CbGeAlD
Amitriptyline—Mianserin—HTR1A—Parkinson's disease	0.000107	0.018	CrCbGaD
Amitriptyline—CYP2E1—spinal cord—Parkinson's disease	0.000106	0.000871	CbGeAlD
Amitriptyline—ABCB1—embryo—Parkinson's disease	0.000106	0.000871	CbGeAlD
Amitriptyline—Thiothixene—DRD2—Parkinson's disease	0.000105	0.0177	CrCbGaD
Amitriptyline—HTR2A—medulla oblongata—Parkinson's disease	0.000103	0.000849	CbGeAlD
Amitriptyline—Trimipramine—SLC6A3—Parkinson's disease	0.000103	0.0173	CrCbGaD
Amitriptyline—CYP2B6—head—Parkinson's disease	0.0001	0.000825	CbGeAlD
Amitriptyline—CHRM3—brain—Parkinson's disease	9.97e-05	0.000822	CbGeAlD
Amitriptyline—HTR1A—brain—Parkinson's disease	9.93e-05	0.000818	CbGeAlD
Amitriptyline—SLC6A2—brain—Parkinson's disease	9.85e-05	0.000811	CbGeAlD
Amitriptyline—HRH1—head—Parkinson's disease	9.78e-05	0.000806	CbGeAlD
Amitriptyline—ADRA2A—head—Parkinson's disease	9.61e-05	0.000792	CbGeAlD
Amitriptyline—Nortriptyline—HTR1A—Parkinson's disease	9.54e-05	0.0161	CrCbGaD
Amitriptyline—CYP2B6—nervous system—Parkinson's disease	9.49e-05	0.000782	CbGeAlD
Amitriptyline—HTR7—brain—Parkinson's disease	9.49e-05	0.000782	CbGeAlD
Amitriptyline—HTR2A—midbrain—Parkinson's disease	9.42e-05	0.000776	CbGeAlD
Amitriptyline—CYP2E1—head—Parkinson's disease	9.4e-05	0.000774	CbGeAlD
Amitriptyline—ABCB1—forebrain—Parkinson's disease	9.35e-05	0.00077	CbGeAlD
Amitriptyline—HRH1—nervous system—Parkinson's disease	9.27e-05	0.000764	CbGeAlD
Amitriptyline—Cyproheptadine—HTR2A—Parkinson's disease	9.24e-05	0.0156	CrCbGaD
Amitriptyline—HTR2A—spinal cord—Parkinson's disease	9.19e-05	0.000757	CbGeAlD
Amitriptyline—Promazine—DRD1—Parkinson's disease	9.17e-05	0.0155	CrCbGaD
Amitriptyline—ADRA1A—brain—Parkinson's disease	9.15e-05	0.000754	CbGeAlD
Amitriptyline—CYP2B6—central nervous system—Parkinson's disease	9.14e-05	0.000753	CbGeAlD
Amitriptyline—ADRA2A—nervous system—Parkinson's disease	9.11e-05	0.00075	CbGeAlD
Amitriptyline—Mianserin—DRD2—Parkinson's disease	9.07e-05	0.0153	CrCbGaD
Amitriptyline—Trimipramine—HTR1A—Parkinson's disease	8.99e-05	0.0152	CrCbGaD
Amitriptyline—DRD2—brain—Parkinson's disease	8.97e-05	0.000739	CbGeAlD
Amitriptyline—Desipramine—SLC6A3—Parkinson's disease	8.97e-05	0.0151	CrCbGaD
Amitriptyline—HRH1—central nervous system—Parkinson's disease	8.93e-05	0.000736	CbGeAlD
Amitriptyline—CYP2E1—nervous system—Parkinson's disease	8.91e-05	0.000734	CbGeAlD
Amitriptyline—ADRA2A—central nervous system—Parkinson's disease	8.77e-05	0.000722	CbGeAlD
Amitriptyline—Imipramine—HTR7—Parkinson's disease	8.7e-05	0.0147	CrCbGaD
Amitriptyline—CYP2E1—central nervous system—Parkinson's disease	8.58e-05	0.000707	CbGeAlD
Amitriptyline—ADRA2A—cerebellum—Parkinson's disease	8.57e-05	0.000706	CbGeAlD
Amitriptyline—Doxepin—HTR1A—Parkinson's disease	8.56e-05	0.0144	CrCbGaD
Amitriptyline—CYP2E1—cerebellum—Parkinson's disease	8.38e-05	0.000691	CbGeAlD
Amitriptyline—Chlorprothixene—DRD2—Parkinson's disease	8.25e-05	0.0139	CrCbGaD
Amitriptyline—HTR2A—head—Parkinson's disease	8.17e-05	0.000673	CbGeAlD
Amitriptyline—Thiothixene—HTR2A—Parkinson's disease	8.11e-05	0.0137	CrCbGaD
Amitriptyline—Nortriptyline—DRD2—Parkinson's disease	8.1e-05	0.0137	CrCbGaD
Amitriptyline—CYP2C8—brain—Parkinson's disease	8.09e-05	0.000667	CbGeAlD
Amitriptyline—Epinastine—ABCB1—Parkinson's disease	7.91e-05	0.0133	CrCbGaD
Amitriptyline—ABCB1—cardiovascular system—Parkinson's disease	7.9e-05	0.000651	CbGeAlD
Amitriptyline—Desipramine—HTR1A—Parkinson's disease	7.86e-05	0.0132	CrCbGaD
Amitriptyline—Nortriptyline—CYP2E1—Parkinson's disease	7.8e-05	0.0131	CrCbGaD
Amitriptyline—HTR2A—nervous system—Parkinson's disease	7.74e-05	0.000638	CbGeAlD
Amitriptyline—Trimipramine—DRD2—Parkinson's disease	7.63e-05	0.0129	CrCbGaD
Amitriptyline—Imipramine—SLC6A3—Parkinson's disease	7.61e-05	0.0128	CrCbGaD
Amitriptyline—HTR2A—central nervous system—Parkinson's disease	7.46e-05	0.000614	CbGeAlD
Amitriptyline—CYP2D6—head—Parkinson's disease	7.44e-05	0.000613	CbGeAlD
Amitriptyline—Thiothixene—CYP2D6—Parkinson's disease	7.41e-05	0.0125	CrCbGaD
Amitriptyline—Promethazine—DRD2—Parkinson's disease	7.35e-05	0.0124	CrCbGaD
Amitriptyline—HTR2A—cerebellum—Parkinson's disease	7.29e-05	0.0006	CbGeAlD
Amitriptyline—Doxepin—DRD2—Parkinson's disease	7.27e-05	0.0123	CrCbGaD
Amitriptyline—CYP2B6—brain—Parkinson's disease	7.26e-05	0.000598	CbGeAlD
Amitriptyline—CYP3A4—nervous system—Parkinson's disease	7.17e-05	0.000591	CbGeAlD
Amitriptyline—HRH1—brain—Parkinson's disease	7.09e-05	0.000584	CbGeAlD
Amitriptyline—CYP2D6—nervous system—Parkinson's disease	7.05e-05	0.000581	CbGeAlD
Amitriptyline—Mianserin—HTR2A—Parkinson's disease	7.01e-05	0.0118	CrCbGaD
Amitriptyline—ADRA2A—brain—Parkinson's disease	6.96e-05	0.000574	CbGeAlD
Amitriptyline—CYP3A4—central nervous system—Parkinson's disease	6.9e-05	0.000569	CbGeAlD
Amitriptyline—Orphenadrine—CYP2E1—Parkinson's disease	6.82e-05	0.0115	CrCbGaD
Amitriptyline—CYP2E1—brain—Parkinson's disease	6.81e-05	0.000561	CbGeAlD
Amitriptyline—CYP2D6—central nervous system—Parkinson's disease	6.79e-05	0.00056	CbGeAlD
Amitriptyline—ABCB1—medulla oblongata—Parkinson's disease	6.75e-05	0.000556	CbGeAlD
Amitriptyline—Desipramine—DRD2—Parkinson's disease	6.67e-05	0.0112	CrCbGaD
Amitriptyline—Imipramine—HTR1A—Parkinson's disease	6.66e-05	0.0112	CrCbGaD
Amitriptyline—CYP2D6—cerebellum—Parkinson's disease	6.64e-05	0.000547	CbGeAlD
Amitriptyline—Promazine—DRD2—Parkinson's disease	6.46e-05	0.0109	CrCbGaD
Amitriptyline—Desipramine—CYP2E1—Parkinson's disease	6.42e-05	0.0108	CrCbGaD
Amitriptyline—Clomipramine—HTR2A—Parkinson's disease	6.41e-05	0.0108	CrCbGaD
Amitriptyline—Mianserin—CYP2D6—Parkinson's disease	6.41e-05	0.0108	CrCbGaD
Amitriptyline—Chlorprothixene—HTR2A—Parkinson's disease	6.38e-05	0.0108	CrCbGaD
Amitriptyline—Nortriptyline—HTR2A—Parkinson's disease	6.26e-05	0.0106	CrCbGaD
Amitriptyline—ABCB1—midbrain—Parkinson's disease	6.17e-05	0.000509	CbGeAlD
Amitriptyline—ABCB1—spinal cord—Parkinson's disease	6.02e-05	0.000496	CbGeAlD
Amitriptyline—HTR2A—brain—Parkinson's disease	5.92e-05	0.000488	CbGeAlD
Amitriptyline—Trimipramine—HTR2A—Parkinson's disease	5.89e-05	0.00994	CrCbGaD
Amitriptyline—Clomipramine—CYP2D6—Parkinson's disease	5.86e-05	0.00988	CrCbGaD
Amitriptyline—Nortriptyline—CYP2D6—Parkinson's disease	5.73e-05	0.00965	CrCbGaD
Amitriptyline—Promethazine—HTR2A—Parkinson's disease	5.68e-05	0.00957	CrCbGaD
Amitriptyline—Imipramine—DRD2—Parkinson's disease	5.66e-05	0.00954	CrCbGaD
Amitriptyline—Doxepin—HTR2A—Parkinson's disease	5.62e-05	0.00947	CrCbGaD
Amitriptyline—Imipramine—CYP2E1—Parkinson's disease	5.45e-05	0.00918	CrCbGaD
Amitriptyline—CYP2D6—brain—Parkinson's disease	5.39e-05	0.000444	CbGeAlD
Amitriptyline—Trimipramine—CYP2D6—Parkinson's disease	5.39e-05	0.00909	CrCbGaD
Amitriptyline—ABCB1—head—Parkinson's disease	5.35e-05	0.000441	CbGeAlD
Amitriptyline—Diphenhydramine—CYP2D6—Parkinson's disease	5.29e-05	0.00893	CrCbGaD
Amitriptyline—Promethazine—CYP2D6—Parkinson's disease	5.19e-05	0.00875	CrCbGaD
Amitriptyline—Desipramine—HTR2A—Parkinson's disease	5.15e-05	0.00869	CrCbGaD
Amitriptyline—Doxepin—CYP2D6—Parkinson's disease	5.14e-05	0.00866	CrCbGaD
Amitriptyline—ABCB1—nervous system—Parkinson's disease	5.07e-05	0.000418	CbGeAlD
Amitriptyline—Promazine—HTR2A—Parkinson's disease	4.99e-05	0.00842	CrCbGaD
Amitriptyline—ABCB1—central nervous system—Parkinson's disease	4.89e-05	0.000403	CbGeAlD
Amitriptyline—ABCB1—cerebellum—Parkinson's disease	4.78e-05	0.000393	CbGeAlD
Amitriptyline—Desipramine—CYP2D6—Parkinson's disease	4.71e-05	0.00795	CrCbGaD
Amitriptyline—Imipramine—HTR2A—Parkinson's disease	4.37e-05	0.00737	CrCbGaD
Amitriptyline—Clomipramine—ABCB1—Parkinson's disease	4.18e-05	0.00705	CrCbGaD
Amitriptyline—Chlorprothixene—ABCB1—Parkinson's disease	4.17e-05	0.00702	CrCbGaD
Amitriptyline—Imipramine—CYP2D6—Parkinson's disease	4e-05	0.00674	CrCbGaD
Amitriptyline—ABCB1—brain—Parkinson's disease	3.88e-05	0.00032	CbGeAlD
Amitriptyline—Trimipramine—ABCB1—Parkinson's disease	3.85e-05	0.00649	CrCbGaD
Amitriptyline—Promethazine—ABCB1—Parkinson's disease	3.71e-05	0.00625	CrCbGaD
Amitriptyline—Doxepin—ABCB1—Parkinson's disease	3.67e-05	0.00619	CrCbGaD
Amitriptyline—Desipramine—ABCB1—Parkinson's disease	3.37e-05	0.00568	CrCbGaD
Amitriptyline—Imipramine—ABCB1—Parkinson's disease	2.85e-05	0.00481	CrCbGaD
Amitriptyline—CYP2E1—Metabolism—GPX1—Parkinson's disease	2.77e-06	1.57e-05	CbGpPWpGaD
Amitriptyline—CYP3A5—Metabolism—GPX1—Parkinson's disease	2.76e-06	1.57e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—APOE—Parkinson's disease	2.76e-06	1.56e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—CYCS—Parkinson's disease	2.75e-06	1.56e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—APOE—Parkinson's disease	2.74e-06	1.56e-05	CbGpPWpGaD
Amitriptyline—OPRD1—Signaling Pathways—CASP3—Parkinson's disease	2.74e-06	1.55e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—NGF—Parkinson's disease	2.73e-06	1.55e-05	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—COMT—Parkinson's disease	2.73e-06	1.55e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—INS—Parkinson's disease	2.73e-06	1.55e-05	CbGpPWpGaD
Amitriptyline—OPRD1—Signaling by GPCR—IL6—Parkinson's disease	2.72e-06	1.54e-05	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—GSTP1—Parkinson's disease	2.72e-06	1.54e-05	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—COMT—Parkinson's disease	2.72e-06	1.54e-05	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—MAOA—Parkinson's disease	2.71e-06	1.54e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	2.71e-06	1.54e-05	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—GSTP1—Parkinson's disease	2.7e-06	1.53e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—INS—Parkinson's disease	2.7e-06	1.53e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—INS—Parkinson's disease	2.7e-06	1.53e-05	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—MAOA—Parkinson's disease	2.7e-06	1.53e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—IGF1R—Parkinson's disease	2.7e-06	1.53e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—NGF—Parkinson's disease	2.69e-06	1.53e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—CYCS—Parkinson's disease	2.69e-06	1.53e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—NGF—Parkinson's disease	2.68e-06	1.52e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—CYP2E1—Parkinson's disease	2.68e-06	1.52e-05	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—HMOX1—Parkinson's disease	2.68e-06	1.52e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—NQO1—Parkinson's disease	2.68e-06	1.52e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—NGF—Parkinson's disease	2.68e-06	1.52e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—NGF—Parkinson's disease	2.67e-06	1.51e-05	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—HMOX1—Parkinson's disease	2.67e-06	1.51e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—EDN1—Parkinson's disease	2.66e-06	1.51e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—NQO1—Parkinson's disease	2.65e-06	1.51e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—NGF—Parkinson's disease	2.64e-06	1.5e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—TH—Parkinson's disease	2.64e-06	1.5e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—NGF—Parkinson's disease	2.63e-06	1.49e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	2.63e-06	1.49e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—APOE—Parkinson's disease	2.62e-06	1.49e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—TH—Parkinson's disease	2.62e-06	1.48e-05	CbGpPWpGaD
Amitriptyline—CYP2B6—Metabolism—MTHFR—Parkinson's disease	2.61e-06	1.48e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—MAOB—Parkinson's disease	2.6e-06	1.48e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—HTR2A—Parkinson's disease	2.6e-06	1.48e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Metabolism—APOE—Parkinson's disease	2.59e-06	1.47e-05	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—ABCB1—Parkinson's disease	2.57e-06	1.46e-05	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—ABCB1—Parkinson's disease	2.56e-06	1.45e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—HTR2A—Parkinson's disease	2.56e-06	1.45e-05	CbGpPWpGaD
Amitriptyline—CYP2E1—Metabolism—MTHFR—Parkinson's disease	2.56e-06	1.45e-05	CbGpPWpGaD
Amitriptyline—CYP3A5—Metabolism—MTHFR—Parkinson's disease	2.55e-06	1.45e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—HTR2A—Parkinson's disease	2.55e-06	1.45e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—HTR2A—Parkinson's disease	2.54e-06	1.44e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—CYCS—Parkinson's disease	2.53e-06	1.44e-05	CbGpPWpGaD
Amitriptyline—OPRD1—Signaling Pathways—MAPK8—Parkinson's disease	2.52e-06	1.43e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—HTR2A—Parkinson's disease	2.51e-06	1.43e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—CYCS—Parkinson's disease	2.51e-06	1.42e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—HTR2A—Parkinson's disease	2.51e-06	1.42e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—CYP2D6—Parkinson's disease	2.51e-06	1.42e-05	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—GSTM1—Parkinson's disease	2.5e-06	1.42e-05	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—GSTM1—Parkinson's disease	2.48e-06	1.41e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—CTGF—Parkinson's disease	2.46e-06	1.4e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—NGF—Parkinson's disease	2.45e-06	1.39e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—COMT—Parkinson's disease	2.44e-06	1.38e-05	CbGpPWpGaD
Amitriptyline—CYP2B6—Metabolism—APOE—Parkinson's disease	2.43e-06	1.38e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—GSTP1—Parkinson's disease	2.43e-06	1.38e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—MAOA—Parkinson's disease	2.42e-06	1.37e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—APOE—Parkinson's disease	2.42e-06	1.37e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Metabolism—INS—Parkinson's disease	2.41e-06	1.37e-05	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—CASP3—Parkinson's disease	2.4e-06	1.36e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—HMOX1—Parkinson's disease	2.39e-06	1.36e-05	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—GPX1—Parkinson's disease	2.39e-06	1.36e-05	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling by GPCR—IL6—Parkinson's disease	2.39e-06	1.35e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—APOE—Parkinson's disease	2.38e-06	1.35e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—COMT—Parkinson's disease	2.38e-06	1.35e-05	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—GPX1—Parkinson's disease	2.38e-06	1.35e-05	CbGpPWpGaD
Amitriptyline—CYP2E1—Metabolism—APOE—Parkinson's disease	2.38e-06	1.35e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—APOE—Parkinson's disease	2.38e-06	1.35e-05	CbGpPWpGaD
Amitriptyline—CYP3A5—Metabolism—APOE—Parkinson's disease	2.37e-06	1.35e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—GSTP1—Parkinson's disease	2.37e-06	1.34e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—APOE—Parkinson's disease	2.37e-06	1.34e-05	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—CASP3—Parkinson's disease	2.37e-06	1.34e-05	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—CASP3—Parkinson's disease	2.37e-06	1.34e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—MAOA—Parkinson's disease	2.36e-06	1.34e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—APOE—Parkinson's disease	2.36e-06	1.34e-05	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—INS—Parkinson's disease	2.35e-06	1.34e-05	CbGpPWpGaD
Amitriptyline—HTR6—Signaling by GPCR—IL6—Parkinson's disease	2.35e-06	1.34e-05	CbGpPWpGaD
Amitriptyline—HTR7—Signaling by GPCR—IL6—Parkinson's disease	2.35e-06	1.33e-05	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—CASP3—Parkinson's disease	2.35e-06	1.33e-05	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—INS—Parkinson's disease	2.34e-06	1.33e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—APOE—Parkinson's disease	2.34e-06	1.33e-05	CbGpPWpGaD
Amitriptyline—HRH4—Signaling Pathways—IL6—Parkinson's disease	2.34e-06	1.33e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—HMOX1—Parkinson's disease	2.34e-06	1.33e-05	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling by GPCR—IL6—Parkinson's disease	2.33e-06	1.32e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—APOE—Parkinson's disease	2.33e-06	1.32e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—HTR2A—Parkinson's disease	2.33e-06	1.32e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—CASP3—Parkinson's disease	2.3e-06	1.31e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—ABCB1—Parkinson's disease	2.3e-06	1.3e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—CYP2E1—Parkinson's disease	2.29e-06	1.3e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling by GPCR—IL6—Parkinson's disease	2.29e-06	1.3e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—NQO1—Parkinson's disease	2.27e-06	1.29e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—COMT—Parkinson's disease	2.24e-06	1.27e-05	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—INS—Parkinson's disease	2.24e-06	1.27e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—TH—Parkinson's disease	2.23e-06	1.27e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—CASP3—Parkinson's disease	2.23e-06	1.27e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—GSTP1—Parkinson's disease	2.23e-06	1.27e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—GSTM1—Parkinson's disease	2.23e-06	1.27e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—MAOA—Parkinson's disease	2.23e-06	1.26e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—COMT—Parkinson's disease	2.22e-06	1.26e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling by GPCR—IL6—Parkinson's disease	2.22e-06	1.26e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—GSTP1—Parkinson's disease	2.21e-06	1.26e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Metabolism—INS—Parkinson's disease	2.21e-06	1.26e-05	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—MTHFR—Parkinson's disease	2.21e-06	1.25e-05	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—MAPK8—Parkinson's disease	2.21e-06	1.25e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—MAOA—Parkinson's disease	2.21e-06	1.25e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—HMOX1—Parkinson's disease	2.2e-06	1.25e-05	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—MTHFR—Parkinson's disease	2.2e-06	1.25e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—HMOX1—Parkinson's disease	2.18e-06	1.24e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—GSTM1—Parkinson's disease	2.18e-06	1.24e-05	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—MAPK8—Parkinson's disease	2.18e-06	1.23e-05	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—MAPK8—Parkinson's disease	2.17e-06	1.23e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—APOE—Parkinson's disease	2.17e-06	1.23e-05	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—MAPK8—Parkinson's disease	2.16e-06	1.23e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—CYCS—Parkinson's disease	2.15e-06	1.22e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—CASP3—Parkinson's disease	2.14e-06	1.21e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—GPX1—Parkinson's disease	2.14e-06	1.21e-05	CbGpPWpGaD
Amitriptyline—NTRK1—Signaling Pathways—IL6—Parkinson's disease	2.13e-06	1.21e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling by GPCR—IL6—Parkinson's disease	2.13e-06	1.21e-05	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—MAPK8—Parkinson's disease	2.11e-06	1.2e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—ABCB1—Parkinson's disease	2.11e-06	1.2e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—ABCB1—Parkinson's disease	2.1e-06	1.19e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—GPX1—Parkinson's disease	2.08e-06	1.18e-05	CbGpPWpGaD
Amitriptyline—CYP2B6—Metabolism—INS—Parkinson's disease	2.07e-06	1.18e-05	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—INS—Parkinson's disease	2.07e-06	1.17e-05	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—APOE—Parkinson's disease	2.06e-06	1.17e-05	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—MAPK8—Parkinson's disease	2.05e-06	1.16e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—GSTM1—Parkinson's disease	2.05e-06	1.16e-05	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—APOE—Parkinson's disease	2.04e-06	1.16e-05	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—INS—Parkinson's disease	2.03e-06	1.15e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—GSTM1—Parkinson's disease	2.03e-06	1.15e-05	CbGpPWpGaD
Amitriptyline—CYP2E1—Metabolism—INS—Parkinson's disease	2.03e-06	1.15e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—CASP3—Parkinson's disease	2.03e-06	1.15e-05	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—INS—Parkinson's disease	2.03e-06	1.15e-05	CbGpPWpGaD
Amitriptyline—CYP3A5—Metabolism—INS—Parkinson's disease	2.03e-06	1.15e-05	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—INS—Parkinson's disease	2.02e-06	1.15e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling by GPCR—IL6—Parkinson's disease	2.02e-06	1.14e-05	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—INS—Parkinson's disease	2.02e-06	1.14e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—CASP3—Parkinson's disease	2.01e-06	1.14e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—CASP3—Parkinson's disease	2.01e-06	1.14e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling by GPCR—IL6—Parkinson's disease	2e-06	1.13e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling by GPCR—IL6—Parkinson's disease	2e-06	1.13e-05	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—INS—Parkinson's disease	2e-06	1.13e-05	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—INS—Parkinson's disease	1.99e-06	1.13e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—MTHFR—Parkinson's disease	1.97e-06	1.12e-05	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—MAPK8—Parkinson's disease	1.97e-06	1.12e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—GPX1—Parkinson's disease	1.96e-06	1.11e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—GPX1—Parkinson's disease	1.95e-06	1.11e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	1.94e-06	1.1e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—MTHFR—Parkinson's disease	1.92e-06	1.09e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—COMT—Parkinson's disease	1.9e-06	1.08e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—CTGF—Parkinson's disease	1.9e-06	1.08e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—GSTP1—Parkinson's disease	1.89e-06	1.07e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—MAOA—Parkinson's disease	1.89e-06	1.07e-05	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—MAPK8—Parkinson's disease	1.87e-06	1.06e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—HMOX1—Parkinson's disease	1.87e-06	1.06e-05	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—INS—Parkinson's disease	1.85e-06	1.05e-05	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—MAPK8—Parkinson's disease	1.85e-06	1.05e-05	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—MAPK8—Parkinson's disease	1.85e-06	1.05e-05	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—APOE—Parkinson's disease	1.84e-06	1.04e-05	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—MTHFR—Parkinson's disease	1.81e-06	1.03e-05	CbGpPWpGaD
Amitriptyline—HRH2—Signaling Pathways—IL6—Parkinson's disease	1.81e-06	1.03e-05	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—MTHFR—Parkinson's disease	1.8e-06	1.02e-05	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—APOE—Parkinson's disease	1.79e-06	1.02e-05	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—ABCB1—Parkinson's disease	1.79e-06	1.02e-05	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	1.77e-06	1e-05	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—INS—Parkinson's disease	1.76e-06	9.97e-06	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—CASP3—Parkinson's disease	1.75e-06	9.95e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—NQO1—Parkinson's disease	1.75e-06	9.93e-06	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—INS—Parkinson's disease	1.75e-06	9.91e-06	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—CASP3—Parkinson's disease	1.74e-06	9.9e-06	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling by GPCR—IL6—Parkinson's disease	1.74e-06	9.88e-06	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—GSTM1—Parkinson's disease	1.74e-06	9.86e-06	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling by GPCR—IL6—Parkinson's disease	1.73e-06	9.83e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—TH—Parkinson's disease	1.72e-06	9.79e-06	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—APOE—Parkinson's disease	1.69e-06	9.58e-06	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—APOE—Parkinson's disease	1.67e-06	9.5e-06	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—CASP3—Parkinson's disease	1.67e-06	9.47e-06	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—GPX1—Parkinson's disease	1.66e-06	9.44e-06	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling by GPCR—IL6—Parkinson's disease	1.66e-06	9.41e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—CYCS—Parkinson's disease	1.66e-06	9.4e-06	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—MAPK8—Parkinson's disease	1.61e-06	9.14e-06	CbGpPWpGaD
Amitriptyline—OPRD1—Signaling Pathways—IL6—Parkinson's disease	1.61e-06	9.13e-06	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—MAPK8—Parkinson's disease	1.6e-06	9.09e-06	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—INS—Parkinson's disease	1.57e-06	8.9e-06	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—CASP3—Parkinson's disease	1.54e-06	8.73e-06	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—MTHFR—Parkinson's disease	1.54e-06	8.72e-06	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—MAPK8—Parkinson's disease	1.53e-06	8.71e-06	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—INS—Parkinson's disease	1.53e-06	8.68e-06	CbGpPWpGaD
Amitriptyline—DRD2—Signaling by GPCR—IL6—Parkinson's disease	1.53e-06	8.68e-06	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—CASP3—Parkinson's disease	1.51e-06	8.59e-06	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—CASP3—Parkinson's disease	1.51e-06	8.57e-06	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—CASP3—Parkinson's disease	1.51e-06	8.55e-06	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling by GPCR—IL6—Parkinson's disease	1.5e-06	8.54e-06	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—CASP3—Parkinson's disease	1.5e-06	8.52e-06	CbGpPWpGaD
Amitriptyline—HRH1—Signaling by GPCR—IL6—Parkinson's disease	1.5e-06	8.52e-06	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling by GPCR—IL6—Parkinson's disease	1.5e-06	8.49e-06	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling by GPCR—IL6—Parkinson's disease	1.49e-06	8.46e-06	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—CASP3—Parkinson's disease	1.49e-06	8.44e-06	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—CASP3—Parkinson's disease	1.48e-06	8.41e-06	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling by GPCR—IL6—Parkinson's disease	1.48e-06	8.38e-06	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling by GPCR—IL6—Parkinson's disease	1.47e-06	8.36e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—COMT—Parkinson's disease	1.47e-06	8.32e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—GSTP1—Parkinson's disease	1.46e-06	8.28e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—MAOA—Parkinson's disease	1.46e-06	8.26e-06	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—INS—Parkinson's disease	1.44e-06	8.18e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—HMOX1—Parkinson's disease	1.44e-06	8.17e-06	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—APOE—Parkinson's disease	1.43e-06	8.11e-06	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—INS—Parkinson's disease	1.43e-06	8.11e-06	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—MAPK8—Parkinson's disease	1.41e-06	8.03e-06	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—IL6—Parkinson's disease	1.41e-06	8e-06	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—MAPK8—Parkinson's disease	1.39e-06	7.9e-06	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—IL6—Parkinson's disease	1.39e-06	7.89e-06	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—MAPK8—Parkinson's disease	1.39e-06	7.88e-06	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—IL6—Parkinson's disease	1.39e-06	7.88e-06	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—MAPK8—Parkinson's disease	1.38e-06	7.86e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—ABCB1—Parkinson's disease	1.38e-06	7.84e-06	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—MAPK8—Parkinson's disease	1.38e-06	7.83e-06	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—IL6—Parkinson's disease	1.38e-06	7.83e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—CASP3—Parkinson's disease	1.38e-06	7.82e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling by GPCR—IL6—Parkinson's disease	1.37e-06	7.77e-06	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—MAPK8—Parkinson's disease	1.37e-06	7.75e-06	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—MAPK8—Parkinson's disease	1.36e-06	7.73e-06	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—IL6—Parkinson's disease	1.35e-06	7.66e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—GSTM1—Parkinson's disease	1.34e-06	7.61e-06	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—IL6—Parkinson's disease	1.31e-06	7.44e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—GPX1—Parkinson's disease	1.28e-06	7.29e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—MAPK8—Parkinson's disease	1.27e-06	7.19e-06	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—IL6—Parkinson's disease	1.26e-06	7.12e-06	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—INS—Parkinson's disease	1.22e-06	6.93e-06	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—IL6—Parkinson's disease	1.19e-06	6.76e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—MTHFR—Parkinson's disease	1.19e-06	6.73e-06	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—IL6—Parkinson's disease	1.18e-06	6.7e-06	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—IL6—Parkinson's disease	1.18e-06	6.7e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—APOE—Parkinson's disease	1.1e-06	6.26e-06	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—IL6—Parkinson's disease	1.03e-06	5.84e-06	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—IL6—Parkinson's disease	1.02e-06	5.81e-06	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—IL6—Parkinson's disease	9.8e-07	5.56e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—INS—Parkinson's disease	9.43e-07	5.35e-06	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—IL6—Parkinson's disease	9.03e-07	5.13e-06	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—IL6—Parkinson's disease	8.89e-07	5.04e-06	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—IL6—Parkinson's disease	8.87e-07	5.03e-06	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—IL6—Parkinson's disease	8.84e-07	5.02e-06	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—IL6—Parkinson's disease	8.81e-07	5e-06	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—IL6—Parkinson's disease	8.73e-07	4.95e-06	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—IL6—Parkinson's disease	8.7e-07	4.94e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—IL6—Parkinson's disease	8.09e-07	4.59e-06	CbGpPWpGaD
